Epilepsy News
Recent news about epilepsy, seizures and treatments.
News Feeds
Epilepsy and Seizure News
Teen seizure-free after two brain surgeries, returns to cheer team -
Kaylee Hill, diagnosed with epilepsy before high school, is now seizure-free after advanced mapping technology guided two successful surgeries.
Want Good Info on Epilepsy Treatment? Don't Ask Dr. TikTok - "These findings are a reminder that people with epilepsy are searching for answers in online spaces every day," said Douglas Nordli III, MD, of the University of Chicago, a co-author of the TikTok ...
First seizure clinic speeds time to diagnosis with pediatric epilepsy - Children referred to a first seizure clinic (FSC) see a neurologist epilepsy specialist within one week, according to a study presented at the annual meeting of the American Epilepsy Society, held ...
GLP-1s Linked to Better Seizure Control in Epilepsy - GLP-1s are linked to lower seizure recurrence, hospitalization, and mortality risk than other glucose-lowering drugs in adults with epilepsy, new research shows.
Nerve Stimulation for Epilepsy: Intracranial Versus Extracranial Approaches Compared - But long-term mortality -- which her group considered a proxy for seizure control -- became substantially worse for patients treated with VNS compared with the intracranial implants, starting at about ...
Epilepsy awareness in the workplace: training and safety tips - More than 35,000 Long Islanders live with epilepsy. Experts urge businesses to provide seizure training, safety plans, and awareness to protect employees and customers.
Health Beat: Treating epilepsy - Nearly three million Americans live with epilepsy. And for one-third of them, anti-seizure medications don't work.
Praxis claims efficacy success in phase 2 seizure trial, setting up approval talks with FDA - “SCN2A and SCN8A DEEs are devastating conditions with extremely high mortality due to the debilitating seizure burden they impose on patients, and there are currently no approved treatment options,” ...
Xenon Showcases New 48-Month Azetukalner OLE Study Data in Epilepsy at AES 2025 - Monthly reductions in seizure frequency of 90.9% among participants treated for ≥48 months in the OLE, with 38% achieving ≥1 year of seizure ...
NEURELIS TO PRESENT CLINICAL DATA AT AMERICAN EPILEPSY SOCIETY ANNUAL MEETING - Neurelis, Inc., the innovator behind VALTOCO® (diazepam nasal spray), today announced it will participate in the American Epilepsy Society (AES) Annual Meeting December 5-9, 2025 in Atlanta. The ...
Want Good Info on Epilepsy Treatment? Don't Ask Dr. TikTok - "These findings are a reminder that people with epilepsy are searching for answers in online spaces every day," said Douglas Nordli III, MD, of the University of Chicago, a co-author of the TikTok ...
First seizure clinic speeds time to diagnosis with pediatric epilepsy - Children referred to a first seizure clinic (FSC) see a neurologist epilepsy specialist within one week, according to a study presented at the annual meeting of the American Epilepsy Society, held ...
GLP-1s Linked to Better Seizure Control in Epilepsy - GLP-1s are linked to lower seizure recurrence, hospitalization, and mortality risk than other glucose-lowering drugs in adults with epilepsy, new research shows.
Nerve Stimulation for Epilepsy: Intracranial Versus Extracranial Approaches Compared - But long-term mortality -- which her group considered a proxy for seizure control -- became substantially worse for patients treated with VNS compared with the intracranial implants, starting at about ...
Epilepsy awareness in the workplace: training and safety tips - More than 35,000 Long Islanders live with epilepsy. Experts urge businesses to provide seizure training, safety plans, and awareness to protect employees and customers.
Health Beat: Treating epilepsy - Nearly three million Americans live with epilepsy. And for one-third of them, anti-seizure medications don't work.
Praxis claims efficacy success in phase 2 seizure trial, setting up approval talks with FDA - “SCN2A and SCN8A DEEs are devastating conditions with extremely high mortality due to the debilitating seizure burden they impose on patients, and there are currently no approved treatment options,” ...
Xenon Showcases New 48-Month Azetukalner OLE Study Data in Epilepsy at AES 2025 - Monthly reductions in seizure frequency of 90.9% among participants treated for ≥48 months in the OLE, with 38% achieving ≥1 year of seizure ...
NEURELIS TO PRESENT CLINICAL DATA AT AMERICAN EPILEPSY SOCIETY ANNUAL MEETING - Neurelis, Inc., the innovator behind VALTOCO® (diazepam nasal spray), today announced it will participate in the American Epilepsy Society (AES) Annual Meeting December 5-9, 2025 in Atlanta. The ...
Neurofeedback News
Rewiring Your Brain: Neurofeedback Goes Mainstream -
Will Strahl walked up to my door with a massive black briefcase in his hand, the kind you could use to tote a dirty bomb. Once inside my living room, he cracked open the case and removed a laptop, a ...
Mindmachines.com Unveils Advanced RoshiWave Mind Machine for Enhanced Mental Wellness Through Neurofeedback Technology - Mindmachines.com has introduced the third generation of its RoshiWave IN-SIGHT Mind Machine, a mental wellness device that employs Dynamic Neuro-Activation technology to help users achieve meditative ...
Neurofeedback Gains Popularity and Lab Attention - You sit in a chair, facing a computer screen, while a clinician sticks electrodes to your scalp with a viscous goop that takes days to wash out of your hair. Wires from the sensors connect to a ...
Brain waves improve with neurofeedback - Neurofeedback — which is sometimes called EEG biofeedback — is used for many conditions and disabilities in which the brain is not working as well as it might. These include attention deficit ...
Q&A: Neurofeedback doctor, mom discusses brain-based treatments that help kids - This month, Dr. Patricia Leigh of the Chapel Hill Brain Centre will lead a discussion about how Montessori education harnesses the natural way children learn. Dr. Leigh, a mom of five, will present on ...
Mindmachines.com Unveils Advanced RoshiWave Mind Machine for Enhanced Mental Wellness Through Neurofeedback Technology - Mindmachines.com has introduced the third generation of its RoshiWave IN-SIGHT Mind Machine, a mental wellness device that employs Dynamic Neuro-Activation technology to help users achieve meditative ...
Neurofeedback Gains Popularity and Lab Attention - You sit in a chair, facing a computer screen, while a clinician sticks electrodes to your scalp with a viscous goop that takes days to wash out of your hair. Wires from the sensors connect to a ...
Brain waves improve with neurofeedback - Neurofeedback — which is sometimes called EEG biofeedback — is used for many conditions and disabilities in which the brain is not working as well as it might. These include attention deficit ...
Q&A: Neurofeedback doctor, mom discusses brain-based treatments that help kids - This month, Dr. Patricia Leigh of the Chapel Hill Brain Centre will lead a discussion about how Montessori education harnesses the natural way children learn. Dr. Leigh, a mom of five, will present on ...
Medical News Today
PubMed
Boldo leaves reduce seizures, neuroinflammation, and hemichannel activity in a murine model of chronic epilepsy -
Epilepsy is a chronic neurological disorder characterized by a propensity for seizures due to an imbalance between excitatory and inhibitory brain activity. This condition also induces neuroinflammation, which contributes to disease progression. Given that hemichannels (HCs) permeabilize the cell membrane of glia playing a critical role in neuroinflammation, we investigated the antiepileptic po...
Pediatric stroke: From emergent evaluation to rehabilitation - Pediatric stroke, though less common than adult stroke, is a significant cause of morbidity and mortality in children, affecting neonates, infants, and adolescents. Strokes in children could be due to ischemic, hemorrhagic, or venous-thrombotic events. Timely recognition and intervention to optimize neurologic outcomes and minimize long-term disability is most critical. Clinical symptoms are de...
Association of Aggression and Anti-seizure Medications in Pediatric Patients: Disproportionality Analysis Using the FDA Adverse Event Reporting System - CONCLUSIONS: Signals of aggression related to different ASMs were identified. Significantly strong signals were observed for perampanel, levetiracetam and brivaracetam. Compared to infants and preschooler, ASMs-associated aggression is more common in school children and teenagers.
PIGA variants are associated with focal epilepsy with favorable outcome and the sub-molecular effect - CONCLUSION: PIGA variants are potentially associated with focal epilepsy with favorable outcome. The sub-molecular effect helps explain phenotype variations.
Educational attainment of children with self-limited epilepsy with CentroTemporal spikes (SELECTS), other epilepsies, and without epilepsy: A retrospective cohort study - CONCLUSIONS: There was a trend for poorer educational achievement for children with SELECTS at KS4; this was only borderline statistically significant in the adjusted model. Children with other epilepsies had an increased risk of poorer attainment across all ages when compared to children without epilepsy.
Cenobamate in adult patients with epilepsy and intellectual disability - OBJECTIVE: In people with intellectual disability (ID), prevalence of epilepsy is up to 50-times higher than in the general population and often difficult to treat. Multiple randomized controlled, observational and retrospective studies have demonstrated favorable efficacy of adjunctive cenobamate (CNB). So far, people with epilepsy and ID (PWE+ID) have remained significantly underrepresented. ...
Pediatric stroke: From emergent evaluation to rehabilitation - Pediatric stroke, though less common than adult stroke, is a significant cause of morbidity and mortality in children, affecting neonates, infants, and adolescents. Strokes in children could be due to ischemic, hemorrhagic, or venous-thrombotic events. Timely recognition and intervention to optimize neurologic outcomes and minimize long-term disability is most critical. Clinical symptoms are de...
Association of Aggression and Anti-seizure Medications in Pediatric Patients: Disproportionality Analysis Using the FDA Adverse Event Reporting System - CONCLUSIONS: Signals of aggression related to different ASMs were identified. Significantly strong signals were observed for perampanel, levetiracetam and brivaracetam. Compared to infants and preschooler, ASMs-associated aggression is more common in school children and teenagers.
PIGA variants are associated with focal epilepsy with favorable outcome and the sub-molecular effect - CONCLUSION: PIGA variants are potentially associated with focal epilepsy with favorable outcome. The sub-molecular effect helps explain phenotype variations.
Educational attainment of children with self-limited epilepsy with CentroTemporal spikes (SELECTS), other epilepsies, and without epilepsy: A retrospective cohort study - CONCLUSIONS: There was a trend for poorer educational achievement for children with SELECTS at KS4; this was only borderline statistically significant in the adjusted model. Children with other epilepsies had an increased risk of poorer attainment across all ages when compared to children without epilepsy.
Cenobamate in adult patients with epilepsy and intellectual disability - OBJECTIVE: In people with intellectual disability (ID), prevalence of epilepsy is up to 50-times higher than in the general population and often difficult to treat. Multiple randomized controlled, observational and retrospective studies have demonstrated favorable efficacy of adjunctive cenobamate (CNB). So far, people with epilepsy and ID (PWE+ID) have remained significantly underrepresented. ...
Science Daily
Brain signal irregularity may provide clues to understanding epileptic process -
Researchers propose a new method to differentiate signals from the epileptic focus from those recorded in other parts of the brain without the presence of an epileptic seizure. This technique may help detect epilepsy-induced features from these signals much quicker than conventional analysis techniques.
Breakthrough tech enables seizure localization in minutes - New research introduces a novel network analysis technology that uses minimally invasive resting state electrophysiological recordings to localize seizure onset brain regions and predict seizure outcomes in just 10 minutes.
Antidepressant use during pregnancy not linked to epilepsy in children - A new study suggests that antidepressant use by mothers during the first trimester of pregnancy does not increase the chances of epilepsy and seizures in babies.
Breakthrough tech enables seizure localization in minutes - New research introduces a novel network analysis technology that uses minimally invasive resting state electrophysiological recordings to localize seizure onset brain regions and predict seizure outcomes in just 10 minutes.
Antidepressant use during pregnancy not linked to epilepsy in children - A new study suggests that antidepressant use by mothers during the first trimester of pregnancy does not increase the chances of epilepsy and seizures in babies.